DAVID PATTERSON: Open Payments
NPI 1457589772 · NORTH DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 130 payments from 16 companies in 2025. Trend: 2023 $1,460 · 2024 $1,679 · 2025 $2,262
Food & beverage: $2,262
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 25 | $398 |
| Vanda Pharmaceuticals Inc. | 13 | $343 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $280 |
| ABBVIE INC. | 21 | $264 |
| E.R. Squibb & Sons, L.L.C. | 10 | $238 |
| Alkermes, Inc. | 10 | $162 |
| Supernus Pharmaceuticals, Inc. | 5 | $109 |
| Janssen Pharmaceuticals, Inc | 4 | $93 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| Collegium Pharmaceutical, Inc. | 4 | $77 |
Products named: REXULTI, FANAPT, CAPLYTA, VRAYLAR, COBENFY, ARISTADA, Qelbree, Auvelity.
Industry payments across MA — which companies pay providers there.
